The endemicity of tropical diseases posed the emergence of an epidemiological scenario marked by overlaps with the progressive circulation of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its Coronavirus Disease 2019 . With the spreading of SARS-CoV-2 in areas endemic to tropical pathogens during regional epidemics, the occurrence and detection of multiple types of coinfections are therefore anticipated. As has been seen with other diseases, communicable and non-communicable, such comorbidity and coinfection outcomes may represent a risk factor for worsening or modifying the evolution to severe and fatal COVID-19, as was already seen with diabetes, hypertension, HIV/AIDS, and tuberculosis, among other public health conditions. This Research Topic collected articles that span the epidemiology, clinical, diagnostic and management aspects of any tropical disease in the context of infection with SARS-CoV-2/COVID-19.Hesse et al. present a case of a 44-year-old female with COVID-19 with adult respiratory distress syndrome ARDS living in a region with high prevalence of hantavirus pulmonary syndrome due to Choclo Orthohantavirus (CHOV). Polymerase chain reaction (PCR) detected both viruses during the early stages of the disease with evidence of the two phylogenetic trees. Genomic sequences of SARS-CoV-2 and CHOV are available in GISAID and GeneBank, respectively. This case described the first coinfection by SARS-CoV-2 and CHOV worldwide. After a prolonged ICU stay, the patient was discharged in good clinical condition. The detection of the coinfection in this patient highlights the importance, during a pandemic, of complementing the testing and diagnosis of an emergent agent, SARS-CoV-2, with other common endemic respiratory pathogens and other zoonotic pathogens, like CHOV, in regions where they are a public health concern to better understand the outcomes of co-infections.Fernandez et al. describe a cohort of COVID-19 inpatients with or without Chagas Disease (CD) admitted to